Nothing Special   »   [go: up one dir, main page]

IE42340B1 - 11,12,-secoprostaglandins - Google Patents

11,12,-secoprostaglandins

Info

Publication number
IE42340B1
IE42340B1 IE1925/75A IE192575A IE42340B1 IE 42340 B1 IE42340 B1 IE 42340B1 IE 1925/75 A IE1925/75 A IE 1925/75A IE 192575 A IE192575 A IE 192575A IE 42340 B1 IE42340 B1 IE 42340B1
Authority
IE
Ireland
Prior art keywords
formula
hydroxy
compounds
pentyl
fluorophenoxy
Prior art date
Application number
IE1925/75A
Other languages
English (en)
Other versions
IE42340L (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IE42340L publication Critical patent/IE42340L/xx
Publication of IE42340B1 publication Critical patent/IE42340B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/515Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an acetalised, ketalised hemi-acetalised, or hemi-ketalised hydroxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
IE1925/75A 1974-09-13 1975-09-03 11,12,-secoprostaglandins IE42340B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/505,445 US3991106A (en) 1974-09-13 1974-09-13 16-Ethers of 8-aza-9-dioxothia-11,12-seco-prostaglandins

Publications (2)

Publication Number Publication Date
IE42340L IE42340L (en) 1976-03-13
IE42340B1 true IE42340B1 (en) 1980-07-16

Family

ID=24010342

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1925/75A IE42340B1 (en) 1974-09-13 1975-09-03 11,12,-secoprostaglandins

Country Status (11)

Country Link
US (1) US3991106A (nl)
JP (1) JPS51125023A (nl)
BE (1) BE833375A (nl)
DE (1) DE2540736A1 (nl)
DK (1) DK385475A (nl)
FR (1) FR2284320A1 (nl)
GB (1) GB1477280A (nl)
IE (1) IE42340B1 (nl)
LU (1) LU73389A1 (nl)
NL (1) NL7510017A (nl)
SE (1) SE7509519L (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091107A (en) * 1973-04-25 1978-05-23 Merck & Co., Inc. 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
US4112236A (en) * 1977-04-04 1978-09-05 Merck & Co., Inc. Interphenylene 8-aza-9-dioxothia-11,12-secoprostaglandins
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
UA67754C2 (uk) 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
AU1293101A (en) 1999-12-22 2001-07-03 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
PT1132086E (pt) 2000-01-31 2006-09-29 Pfizer Prod Inc Utilizacao de agonistas selectivos para o receptor da prostaglandina (pge2) 4 (ep4) para o tratamento de falha renal aguda e cronica
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6858614B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
GB0610804D0 (en) * 2006-05-31 2006-07-12 Portela & Ca Sa New crystal forms
JP2011506315A (ja) * 2007-12-05 2011-03-03 バイアル−ポルテラ アンド シーエー,エス.エー. 新たな塩、及び結晶形
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CN108484513A (zh) 2012-12-17 2018-09-04 帕里昂科学公司 可用于治疗由黏膜水化不足造成的疾病的氯-吡嗪甲酰胺衍生物
EP2931712B8 (en) 2012-12-17 2018-05-23 Parion Sciences, Inc. 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz

Also Published As

Publication number Publication date
SE7509519L (sv) 1976-03-15
FR2284320A1 (fr) 1976-04-09
BE833375A (fr) 1976-03-12
NL7510017A (nl) 1976-03-16
JPS51125023A (en) 1976-11-01
FR2284320B1 (nl) 1980-05-30
IE42340L (en) 1976-03-13
DK385475A (da) 1976-03-14
GB1477280A (en) 1977-06-22
US3991106A (en) 1976-11-09
LU73389A1 (nl) 1976-08-13
DE2540736A1 (de) 1976-03-25

Similar Documents

Publication Publication Date Title
IE42340B1 (en) 11,12,-secoprostaglandins
US3975399A (en) 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
US4033996A (en) 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
US4022794A (en) Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and method of preparation thereof
US4066692A (en) 11,12-secoprostaglandins
US4102888A (en) 3-Thiazolidinyl heptanoic acids
US4126629A (en) Substituted phenoxy-tridecenoic acids/esters
US4260771A (en) Interphenylene 9-thia-11-oxo-12-azaprostanoic acid compounds
IE46699B1 (en) 11,12-secoprostaglandins
US4091107A (en) 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
US3989749A (en) 11,12-Secoprostaglandins
US4085125A (en) 9-Thia-, 9-oxothia-, and 9-dioxothia-11,12-seco-prostaglandins and processes
US4092356A (en) 11,12-Secoprostaglandins
US3835179A (en) Novel 15-substituted prostanoic acids and esters
JPS624390B2 (nl)
US3959263A (en) Prostaglandin intermediate
US4105854A (en) Prostanoic acid derivatives
US4229585A (en) Fluoro-prostaglandins
EP0032432A1 (en) Prostanoid compounds and their preparation and pharmaceutical formulations
JPS609711B2 (ja) 9−デオキシ−9−メチレンpgf類似体類
US4241215A (en) Prostane derivatives
JPS6049632B2 (ja) 16−フェノキシ プロスタ グランジン類似体
JPS6032624B2 (ja) 2,2−ジフルオロpgf類似体
CA1044701A (en) Seco-prostaglandins
US4036871A (en) 11-Substituted prostaglandins